| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5824396 | Clinical Therapeutics | 2016 | 12 Pages |
Abstract
Accumulating data suggest that certain alarmins, High-mobility group nucleosome-binding protein 1 (HMGN1) in particular, contribute to the generation of antitumor immunity. Some alarmins can also be used as cancer biomarkers. Therefore, alarmins can potentially be applied for our fight against cancers.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Yingjie PhD, De MD, PhD, Joost J. MD,